HUTCHISON CHINA MEDITECH LTD's ticker is HCM and the CUSIP is 44842L103. A total of 98 filers reported holding HUTCHISON CHINA MEDITECH LTD in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $1,501,000 | -66.9% | 79,328 | -38.5% | 0.00% | -50.0% |
| Q4 2021 | $4,528,000 | +34.6% | 129,083 | +40.5% | 0.00% | 0.0% |
| Q3 2021 | $3,364,000 | -0.6% | 91,896 | +6.6% | 0.00% | 0.0% |
| Q2 2021 | $3,386,000 | +88.0% | 86,218 | +35.3% | 0.00% | +100.0% |
| Q1 2021 | $1,801,000 | +1.5% | 63,742 | +15.0% | 0.00% | 0.0% |
| Q4 2020 | $1,775,000 | 0.0% | 55,435 | +0.9% | 0.00% | 0.0% |
| Q3 2020 | $1,775,000 | -16.5% | 54,944 | -28.7% | 0.00% | -50.0% |
| Q2 2020 | $2,126,000 | +73.1% | 77,067 | +12.0% | 0.00% | +100.0% |
| Q1 2020 | $1,228,000 | -23.2% | 68,810 | +7.9% | 0.00% | 0.0% |
| Q4 2019 | $1,598,000 | +19.3% | 63,751 | -15.0% | 0.00% | 0.0% |
| Q3 2019 | $1,339,000 | -42.0% | 75,040 | -28.5% | 0.00% | -50.0% |
| Q2 2019 | $2,308,000 | -23.6% | 104,896 | +6.2% | 0.00% | -33.3% |
| Q1 2019 | $3,022,000 | +351.0% | 98,816 | +240.4% | 0.00% | +200.0% |
| Q4 2018 | $670,000 | – | 29,028 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GENERAL ATLANTIC, L.P. | 4,000,000 | $67,760,000 | 1.05% |
| M&G INVESTMENT MANAGEMENT LTD | 7,084,834 | $120,442,178 | 0.54% |
| Bellevue Group AG | 1,802,963 | $30,584,761 | 0.49% |
| AIA Group Ltd | 391,278 | $6,628,249 | 0.32% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 182,052 | $3,083,961 | 0.12% |
| SCHRODER INVESTMENT MANAGEMENT GROUP | 4,219,168 | $71,472,706 | 0.11% |
| Hennion & Walsh Asset Management, Inc. | 51,735 | $876,391 | 0.06% |
| Allianz Asset Management GmbH | 1,644,999 | $27,866,283 | 0.05% |
| Janney Capital Management LLC | 17,203 | $291 | 0.02% |
| ACADIAN ASSET MANAGEMENT LLC | 193,811 | $3,268 | 0.01% |